Graham Capital Management, L.P. Castle Biosciences Inc Transaction History
Graham Capital Management, L.P.
- $4.38 Billion
- Q1 2025
A detailed history of Graham Capital Management, L.P. transactions in Castle Biosciences Inc stock. As of the latest transaction made, Graham Capital Management, L.P. holds 68,385 shares of CSTL stock, worth $1.1 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
68,385
Previous 41,676
64.09%
Holding current value
$1.1 Million
Previous $1.11 Million
23.33%
% of portfolio
0.03%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding CSTL
# of Institutions
192Shares Held
26.6MCall Options Held
9.5KPut Options Held
5K-
Black Rock Inc. New York, NY3.04MShares$48.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.05MShares$32.9 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.47MShares$23.6 Million0.02% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.27MShares$20.3 Million2.07% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.2MShares$19.3 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $423M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...